Online ISSN: 1945-4589
Learn about our FREE Post-Publication Promotion Services
Editorial Volume 9, Issue 6 pp 1475—1476

BET-inhibitors as sensitizers for BH3-mimetics

Chiaki Tsuge Ishida1, , Georg Karpel-Massler2, , Markus D. Siegelin1, ,

  • 1 Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA
  • 2 Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany

Received: June 16, 2017       Published: June 26, 2017      

https://doi.org/10.18632/aging.101259
How to Cite

Copyright: © 2017 Ishida et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download PDF
Corresponding Author

Markus D. Siegelin
ms4169@cumc.columbia.edu

Keywords
Bromodomain Extraterminal domain proteins inhibitors BH3-mimetics drug combination therapies cell death cancer